Brief: Recursion to Host Webinar on Tupelo Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis on Dec. 8
Dec 1 (Reuters) - Recursion Pharmaceuticals Inc RXRX.O: RECURSION ANNOUNCES WEBINAR FOR UPCOMING CLINICAL DATA READOUT ON THE TUPELO PHASE 1B/2 TRIAL OF REC-4881 IN FAMILIAL ADENOMATOUS POLYPOSIS ON DECEMBER 8, 2025 Source text: ID:nGNX15GLWS Further company coverage: RXRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Recursion Pharmaceuticals
See all newsBrief: Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model
Brief: Recursion Pharmaceuticals Enters Amendment To Master Agreement With Tempus On Sept 15, 2026 - SEC Filing
Recursion Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Recursion Pharmaceuticals Q2 revenue misses estimates, cuts 2026 expense outlook
Brief: Recursion Pharmaceuticals Q2 Operating Revenue USD 7.303 Million Vs. IBES Estimate USD 11.9 Million